Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancer
- 1 May 1985
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 145 (5) , 863-864
- https://doi.org/10.1001/archinte.145.5.863
Abstract
Ketoconazole, an imidazole derivative with antifungal properties, was shown to inhibit ACTH and androgen production. A patient with small-cell lung cancer and Cushing''s syndrome secondary to ectopic secretion of ACTH in whom it was necessary to discontinue chemotherapy was treated. The patient was treated with ketoconazole, with a resultant reduction in urinary free cortisol and ketosteroid excretion and improvement in electrolyte balance. Ketoconazole may be a useful adjunct in the treatment of small-cell lung cancer or other malignancies associated with excessive corticosteroid production or as a hormonal therapy in breast or prostatic cancer.This publication has 5 references indexed in Scilit:
- Ketoconazole blocks testosterone synthesisArchives of internal medicine (1960), 1982
- Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifenCancer, 1982
- Ketoconazole Blocks Adrenal Steroid SynthesisAnnals of Internal Medicine, 1982
- Determination of the antifungal agent, ketoconazole, in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967